>
Retrasib SA logo

RTRA - Retrasib SA Share Price

RON12.1 1.5  14.2%

Last Trade - 20/04/21

Sector
Industrials
Size
Micro Cap
Market Cap £9.84m
Enterprise Value £23.7m
Revenue £35.4m
Position in Universe 553rd / 794
Bullish
Bearish
Unlock RTRA Revenue
Momentum
Relative Strength (%)
1m -0.17%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
61.9 61.3 122.7 116.9 151 202.7 +26.8%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, RetrasibSA revenues increased 34% to RON202.7M. Net loss increased16% to RON3.1M. Revenues reflect an increase in demand forthe Company's products and services due to favorable marketconditions. Higher net loss reflects Selling/General/Admin.Expense increase of 57% to RON20.3M (expense), Fair ValueAdjustments on Other Assets increase from RON2.4M (income)to RON1.9M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

RTRA Revenue Unlock RTRA Revenue

Net Income

RTRA Net Income Unlock RTRA Revenue

Normalised EPS

RTRA Normalised EPS Unlock RTRA Revenue

PE Ratio Range

RTRA PE Ratio Range Unlock RTRA Revenue

Dividend Yield Range

RTRA Dividend Yield Range Unlock RTRA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
RTRA EPS Forecasts Unlock RTRA Revenue
Profile Summary

Retrasib SA is a Romania-based company engaged in the industrial sector. The Company specializes in the manufacture of transformers and autotransformers for generation, transport and distribution of electrical energy. Retrasib SA’s products portfolio encompasses high and medium voltage transformers and autotransformers, special transformers and autotransformers for mobile substations, metallurgy, chemistry, transport by railway, power plant and equipment for neutral treatment. In addition the Company provides various services, including diagnostic, maintenance and modernization of power transformers in the factories and at transformer site. Its main customers are Transelectrica SA, Hidroelectrica SA and Electrica SA, among others. The main shareholder of the Company is SGB-SMIT International GmbH.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated April 16, 1993
Public Since December 3, 1996
No. of Shareholders: n/a
No. of Employees: n/a
Sector Industrials
Industry Machinery, Equipment & Components
Index
Exchange Bucharest Stock Exchange
Shares in Issue 4,663,501
Free Float (0.0%)
Eligible for
ISAs
SIPPs
RTRA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for RTRA
Upcoming Events for RTRA
Frequently Asked Questions for Retrasib SA
What is the Retrasib SA share price?

As of 20/04/21, shares in Retrasib SA are trading at RON12.1, giving the company a market capitalisation of £9.84m. This share price information is delayed by 15 minutes.

How has the Retrasib SA share price performed this year?

Shares in Retrasib SA are currently trading at RON12.1 and the price has moved by 45.78% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Retrasib SA price has moved by 13.39% over the past year.

What are the analyst and broker recommendations for Retrasib SA?

There are no analysts currently covering Retrasib SA.

When will Retrasib SA next release its financial results?

Retrasib SA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Retrasib SA dividend yield?

Retrasib SA does not currently pay a dividend.

Does Retrasib SA pay a dividend?

Retrasib SA does not currently pay a dividend.

When does Retrasib SA next pay dividends?

Retrasib SA does not currently pay a dividend.

How do I buy Retrasib SA shares?

To buy shares in Retrasib SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Retrasib SA?

Shares in Retrasib SA are currently trading at RON12.1, giving the company a market capitalisation of £9.84m.

Where are Retrasib SA shares listed? Where are Retrasib SA shares listed?

Here are the trading details for Retrasib SA:

Country of listing: Romania
Exchange: BUH
Ticker Symbol: RTRA
What kind of share is Retrasib SA?

Based on an overall assessment of its quality, value and momentum, Retrasib SA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Retrasib SA share price forecast 2021?

We were not able to load any forecast data for Retrasib SA.

How can I tell whether the Retrasib SA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Retrasib SA. Over the past six months, the relative strength of its shares against the market has been 30.67%. At the current price of RON12.1, shares in Retrasib SA are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Retrasib SA PE Ratio?

We were not able to find PE ratio data for Retrasib SA.

Who are the key directors of Retrasib SA?

Retrasib SA's management team is headed by:

Franz Schatzl - DRC
Claudia Gherghel-Diaconeasa - CEO
Tilo Dorn - CHM
Emilian Draghici - COO
Roxana Panaitescu - CFO
Ulrich Voss - DRC
Markus Spliethoff - DRC
Matthias Gradl - DRC
Who are the major shareholders of Retrasib SA?

Here are the top five shareholders of Retrasib SA based on the size of their shareholding:

SGB-SMIT Group Corporation
Percentage owned: 98.26% (4.58m shares)
Similar to RTRA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.